BridgeMD
New treatment option for Lung Cancer
Official title Involvement of General Practitioners in Lung Cancer Screening
ClinicalTrials.gov ID: NCT06956040
What this study is testing
- What it's testing
- The main objective is to evaluate the adherence of smoking patients to lung cancer screening by low-dose CT scan, when proposed by the general practitioner.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 to 74
You may be able to join if
- Adults aged 50-74
- Active smoker or weaned smoker for less than 15 years, of at least 20 pack-years
- Affiliation with a social security scheme or CMU (beneficiary or beneficiary entitled)
- Written informed consent prior to study participation
You likely can't join if
- History of lung cancer
- Thoracic CT scan performed within the previous year
- 1-year follow-up not possible
- Inability to travel independently to Hôpital Cochin or Hôpital Bichat for scans
- People with severe co-morbidities contraindicating exploration and/or management of lung cancers
- People in poor general health (=PS2 and above)
See the full eligibility criteria
- Adults aged 50-74
- Active smoker or weaned smoker for less than 15 years, of at least 20 pack-years
- Affiliation with a social security scheme or CMU (beneficiary or beneficiary entitled)
- Written informed consent prior to study participation
- History of lung cancer
- Thoracic CT scan performed within the previous year
- 1-year follow-up not possible
- Inability to travel independently to Hôpital Cochin or Hôpital Bichat for scans
- People with severe co-morbidities contraindicating exploration and/or management of lung cancers
- People in poor general health (=PS2 and above)
- People with a history of cancer under active surveillance by thoracic computed tomography (CT and PET scans)
- People with rest dyspnea (=mMRC4)
- Recent weight loss, altered general condition or hemoptysis, raising suspicion of progressive lung cancer
- Signs of respiratory infection (fever, productive cough)
- Patients under guardianship, curatorship or protected adults
- Inability to give free written informed consent prior to study participation
The study team makes the final eligibility decision.
Where it's taking place
- Paris, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years to 74 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Paris, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.